As we move towards CTx-1301’s 31May26 target action date, Cingulate CEO Shane Schaffer describes payors reactions to the medicine. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #PDUFA #NDAFails
youtube.com/shorts/nIzin...
0
0
0
0